deltatrials
Terminated PHASE1 INTERVENTIONAL 1-arm NCT00886951

Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease

Evaluation of [123I] MNI-388 and 123-I MNI-390 and SPECT as Markers of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Sponsor: Institute for Neurodegenerative Disorders

Conditions Alzheimer's Disease
Interventions I123MNI388/I123MNI390
Updated 11 times since 2017 Last updated: Apr 1, 2019 Started: Mar 31, 2009 Primary completion: Mar 31, 2009 Completion: Mar 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

There seemed to be no uptake of the ligand in the areas of the brain expected for subjects with amyloid.

Other terminated trials from Institute for Neurodegenerative Disorders

See all terminations from Institute for Neurodegenerative Disorders

Other Alzheimer's Disease trials with similar outcome

Browse all Alzheimer's Disease trials

A PHASE1 clinical study on Alzheimer's Disease, this trial is terminated or withdrawn. The trial is conducted by Institute for Neurodegenerative Disorders and has accumulated 11 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshotTerminated~Aug 2017 – ~May 2018 · 9 months · monthly snapshotTerminated~May 2018 – ~Jun 2018 · 31 days · monthly snapshotTerminated~Jun 2018 – ~May 2019 · 11 months · monthly snapshotTerminated~May 2019 – ~Nov 2020 · 18 months · monthly snapshotTerminated~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE1

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE1

  5. Nov 2020 — Jan 2021 [monthly]

    Terminated PHASE1

▶ Show 6 earlier versions

  1. May 2019 — Nov 2020 [monthly]

    Terminated PHASE1

  2. Jun 2018 — May 2019 [monthly]

    Terminated PHASE1

  3. May 2018 — Jun 2018 [monthly]

    Terminated PHASE1

  4. Aug 2017 — May 2018 [monthly]

    Terminated PHASE1

  5. Feb 2017 — Aug 2017 [monthly]

    Terminated PHASE1

  6. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE1

    First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institute for Neurodegenerative Disorders
Data source: Institute for Neurodegenerative Disorders

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations